Lupin Appoints Brian Savage as President, Chief Legal Officer

Lupin Limited announced the appointment of Mr. Brian Savage as Senior Management Personnel, designated as President, Chief Legal Officer, effective October 22, 2026. Mr. Savage will be responsible for overseeing the company's Global Legal, Compliance, and IP functions. He brings extensive legal leadership experience from the global pharmaceutical industry, including previous roles at Teva Pharmaceuticals and Dechert LLP. His expertise includes legal and regulatory matters, litigation management, and strategic business partnering.